Carrie Bearden received her Ph.D. in Clinical Psychology from the University of Pennsylvania and joined the UCLA faculty in 2003. Currently, she is a Professor in the Semel Institute for Neuroscience and Human Behavior and Brain Research Institute, with a joint appointment in the Department of Psychology at UCLA. Dr. Bearden’s research aims to understand neurobiological risk factors for the development of serious mental illness in youth, using converging methods to study cognition and neuroanatomy in clinical high-risk cohorts (e.g., adolescents with early symptoms of psychosis), and in highly penetrant genetic subtypes. Her recent work focuses on translational approaches to understanding disrupted brain circuitry in developmental neuropsychiatric disorders, particularly in the context of unique genetic populations. She is the Director of the Staglin Music Festival Center for the Assessment and Prevention of Prodromal States (CAPPS), and a Principal Investigator of the multi-site Psychosis Risk Outcomes Network (ProNET), part of the Accelerating Medicine Partnership for Schizophrenia (AMP-SCZ TM ) program, which aims to identify biomarkers predicting psychosis onset in at-risk youth, and leads the 22q11 disease working group of the ENIGMA (Enhancing Neuroimaging Genetics Through Meta-Analysis) consortium. She co-directs the Neurobehavioral Genetics Training Grant at UCLA and is Assistant Editor of Biological Psychiatry, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, and on the editorial boards of Schizophrenia Bulletin, Neuropsychology and Development and Psychopathology. She is a Fellow of the American College of Neuropsychopharmacology and chairs the DSM-V Serious Mental Disorders Committee and the Women’s Leadership Group of the Society of Biological Psychiatry. Dr. Bearden has received numerous awards and honors, both for her research achievements and for teaching and mentorship.